Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCIP vs Control Plasma in Outpatient COVID-19
NCT04373460Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jun 2020
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by Johns Hopkins University. Started Jun 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04373460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373460.